Silence Therapeutics PLC (SLN) — Cash Flow-to-Debt Ratio
Silence Therapeutics PLC (SLN) has a Cash Flow-to-Debt Ratio of -0.15x as of September 2025, meaning its operating cash flow of $-10.89 Million could theoretically repay 0% of its total liabilities ($72.73 Million) in one year. See SLN free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Silence Therapeutics PLC Cash Flow-to-Debt Ratio (1995–2024)
Historical debt coverage capacity for Silence Therapeutics PLC across 30 annual periods. Also explore net asset growth rate of Silence Therapeutics PLC to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for Silence Therapeutics PLC (1995–2024)
Year-by-year debt coverage analysis for Silence Therapeutics PLC. For market capitalisation and broader financial context, see Silence Therapeutics PLC stock valuation.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | -0.99x | $-67.64 Million | $68.61 Million | ▼ -144.2% |
| 2023 | -0.40x | $-39.35 Million | $97.45 Million | ▲ +39.5% |
| 2022 | -0.67x | $-57.04 Million | $85.43 Million | ▼ -737.3% |
| 2021 | 0.10x | $9.19 Million | $87.67 Million | ▲ +174.8% |
| 2020 | -0.14x | $-10.78 Million | $76.91 Million | ▼ -304.2% |
| 2019 | 0.07x | $1.73 Million | $25.17 Million | ▲ +101.6% |
| 2018 | -4.38x | $-16.76 Million | $3.83 Million | ▼ -21.1% |
| 2017 | -3.61x | $-9.60 Million | $2.66 Million | ▲ +42.2% |
| 2016 | -6.25x | $-10.07 Million | $1.61 Million | ▲ +15.3% |
| 2015 | -7.38x | $-8.26 Million | $1.12 Million | ▼ -57.2% |
| 2014 | -4.70x | $-9.46 Million | $2.01 Million | ▼ -19.9% |
| 2013 | -3.92x | $-6.76 Million | $1.72 Million | ▲ +22.9% |
| 2012 | -5.08x | $-4.88 Million | $959.00K | ▼ -25.4% |
| 2011 | -4.06x | $-5.11 Million | $1.26 Million | ▲ +35.2% |
| 2010 | -6.26x | $-10.55 Million | $1.69 Million | ▼ -183.2% |
| 2009 | -2.21x | $-4.65 Million | $2.10 Million | ▲ +70.4% |
| 2008 | -7.47x | $-6.98 Million | $935.00K | ▼ -251.0% |
| 2007 | -2.13x | $-3.83 Million | $1.80 Million | ▲ +44.9% |
| 2006 | -3.86x | $-4.03 Million | $1.04 Million | ▼ -106.1% |
| 2005 | -1.87x | $-2.78 Million | $1.49 Million | ▲ +36.1% |
| 2004 | -2.93x | $-2.48 Million | $846.00K | ▼ -88.2% |
| 2003 | -1.56x | $-2.04 Million | $1.31 Million | ▲ +13.0% |
| 2002 | -1.79x | $-1.84 Million | $1.03 Million | ▲ +43.1% |
| 2001 | -3.15x | $-2.28 Million | $725.00K | ▼ -6.1% |
| 2000 | -2.97x | $-2.86 Million | $964.00K | ▼ -319.4% |
| 1999 | -0.71x | $-1.13 Million | $1.60 Million | ▲ +76.4% |
| 1998 | -3.00x | $-1.81 Million | $603.00K | ▼ -26.3% |
| 1997 | -2.37x | $-1.52 Million | $640.00K | ▼ -36.1% |
| 1996 | -1.74x | $-727.00K | $417.00K | ▲ +31.0% |
| 1995 | -2.53x | $-761.00K | $301.00K | — |